Cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effects
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , |
| Formato: | conferenceObject |
| Idioma: | eng |
| Publicado em: |
2018
|
| Assuntos: | |
| Texto completo: | https://www.valueinhealthjournal.com/article/S1098-3015(10)63296-2/abstract?code=jval-site |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/39154 |